Van Vliet David A 4
4 · KV PHARMACEUTICAL CO /DE/ · Filed Jan 15, 2009
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA / KVB
Van Vliet David A
Interim Pres./ Interim CEO, KV
Transactions
- Award
Option to Purchase
2009-01-13+150,000→ 150,000 totalExercise: $2.95Exp: 2019-01-13→ Class A Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option vests in three installments: 33% on January 13, 2010, 33% on January 13, 2011 and 34% on January 13, 2012.